201 related articles for article (PubMed ID: 20569520)
1. Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.
Arnt J; Bang-Andersen B; Grayson B; Bymaster FP; Cohen MP; DeLapp NW; Giethlen B; Kreilgaard M; McKinzie DL; Neill JC; Nelson DL; Nielsen SM; Poulsen MN; Schaus JM; Witten LM
Int J Neuropsychopharmacol; 2010 Sep; 13(8):1021-33. PubMed ID: 20569520
[TBL] [Abstract][Full Text] [Related]
2. Characterization of [³H]Lu AE60157 ([³H]8-(4-methylpiperazin-1-yl)-3-phenylsulfonylquinoline) binding to 5-hydroxytryptamine₆ (5-HT₆) receptors in vivo.
Witten L; Bang-Andersen B; Nielsen SM; Miller S; Christoffersen CT; Stensbøl TB; Brennum LT; Arnt J
Eur J Pharmacol; 2012 Feb; 676(1-3):6-11. PubMed ID: 22155399
[TBL] [Abstract][Full Text] [Related]
3. The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats.
Horiguchi M; Huang M; Meltzer HY
J Pharmacol Exp Ther; 2011 Aug; 338(2):605-14. PubMed ID: 21558435
[TBL] [Abstract][Full Text] [Related]
4. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283
[TBL] [Abstract][Full Text] [Related]
5. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
Hirst WD; Stean TO; Rogers DC; Sunter D; Pugh P; Moss SF; Bromidge SM; Riley G; Smith DR; Bartlett S; Heidbreder CA; Atkins AR; Lacroix LP; Dawson LA; Foley AG; Regan CM; Upton N
Eur J Pharmacol; 2006 Dec; 553(1-3):109-19. PubMed ID: 17069795
[TBL] [Abstract][Full Text] [Related]
6. Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.
Grychowska K; Satała G; Kos T; Partyka A; Colacino E; Chaumont-Dubel S; Bantreil X; Wesołowska A; Pawłowski M; Martinez J; Marin P; Subra G; Bojarski AJ; Lamaty F; Popik P; Zajdel P
ACS Chem Neurosci; 2016 Jul; 7(7):972-83. PubMed ID: 27100049
[TBL] [Abstract][Full Text] [Related]
7. Lu 35-138 ((+)-(S)-3-{1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-3,6-dihydro-2H-pyridin-4-yl}-6-chloro-1H-indole), a dopamine D4 receptor antagonist and serotonin reuptake inhibitor: characterisation of its in vitro profile and pre-clinical antipsychotic potential.
Hertel P; Didriksen M; Pouzet B; Brennum LT; Søby KK; Larsen AK; Christoffersen CT; Ramirez T; Marcus MM; Svensson TH; Di Matteo V; Esposito E; Bang-Andersen B; Arnt J
Eur J Pharmacol; 2007 Nov; 573(1-3):148-60. PubMed ID: 17689529
[TBL] [Abstract][Full Text] [Related]
8. Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.
Rajagopal L; Massey BW; Michael E; Meltzer HY
Psychopharmacology (Berl); 2016 Feb; 233(4):649-60. PubMed ID: 26558619
[TBL] [Abstract][Full Text] [Related]
9. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of alpha7 nicotinic receptors.
Hashimoto K; Fujita Y; Ishima T; Hagiwara H; Iyo M
Eur J Pharmacol; 2006 Dec; 553(1-3):191-5. PubMed ID: 17094961
[TBL] [Abstract][Full Text] [Related]
10. Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.
Idris N; Neill J; Grayson B; Bang-Andersen B; Witten LM; Brennum LT; Arnt J
Psychopharmacology (Berl); 2010 Jan; 208(1):23-36. PubMed ID: 19851757
[TBL] [Abstract][Full Text] [Related]
11. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
Depoortère R; Auclair AL; Bardin L; Bruins Slot L; Kleven MS; Colpaert F; Vacher B; Newman-Tancredi A
Br J Pharmacol; 2007 May; 151(2):266-77. PubMed ID: 17375085
[TBL] [Abstract][Full Text] [Related]
12. The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.
Horiguchi M; Meltzer HY
Psychopharmacology (Berl); 2012 May; 221(2):205-15. PubMed ID: 22227609
[TBL] [Abstract][Full Text] [Related]
13. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
[TBL] [Abstract][Full Text] [Related]
14. Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities.
Schaffhauser H; Mathiasen JR; Dicamillo A; Huffman MJ; Lu LD; McKenna BA; Qian J; Marino MJ
Biochem Pharmacol; 2009 Oct; 78(8):1035-42. PubMed ID: 19549510
[TBL] [Abstract][Full Text] [Related]
15. Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.
Horiguchi M; Hannaway KE; Adelekun AE; Jayathilake K; Meltzer HY
Neuropsychopharmacology; 2012 Sep; 37(10):2175-83. PubMed ID: 22739469
[TBL] [Abstract][Full Text] [Related]
16. ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia.
Yamazaki M; Harada K; Yamamoto N; Yarimizu J; Okabe M; Shimada T; Ni K; Matsuoka N
Eur Neuropsychopharmacol; 2014 Oct; 24(10):1698-708. PubMed ID: 25108314
[TBL] [Abstract][Full Text] [Related]
17. D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats.
Horiguchi M; Hannaway KE; Adelekun AE; Huang M; Jayathilake K; Meltzer HY
Behav Brain Res; 2013 Feb; 238():36-43. PubMed ID: 23018127
[TBL] [Abstract][Full Text] [Related]
18. Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT(1A) partial agonism.
Horiguchi M; Meltzer HY
Behav Brain Res; 2013 Jun; 247():158-64. PubMed ID: 23538066
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus.
Herrik KF; Mørk A; Richard N; Bundgaard C; Bastlund JF; de Jong IEM
Neuropharmacology; 2016 Aug; 107():351-363. PubMed ID: 27039041
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
